期刊文献+

多聚乙烯基亚胺介导的pOSP1-HSVtk基因对卵巢癌的抗瘤研究 被引量:1

Anti-Tumor Study of pOSP1-HSVtk Gene Therapy by Polyethylenimine Mediated Transfection in Ovarian Cancer
下载PDF
导出
摘要 目的:研究多聚乙烯基亚胺(PEI)介导的卵巢特异性启动子调控下的自杀基因对卵巢癌的扰肿瘤作用。方法:(1)将卵巢特异性启动子调控下的真核表达质粒pOSP1-HSVtk利用PEI导入人卵巢癌细胞SKOV3,人肺癌细胞NCI-H460和人肝癌细胞HepG2,MTT法测定GCV对三种肿瘤细胞的杀伤作用;(2)建立卵巢癌移植瘤模型,瘤周注射PEI/pOSP1-HSVtk复合物,通过HPLC监测体内GCV浓度的变化来评价TK基因在肿瘤组织中的表达效率;同时记录裸鼠的体重、瘤体大小及瘤重,计算体积和重量抑瘤率,并进行肿瘤组织的病理学和TUNEL检测。结果:(1)GCV仅对SKOV3细胞:具有杀伤作用;(2)与对照组相比,GCV的浓度在转染pOSP1-HSVtk的肿瘤组织局部显著降低(0.05>P>0.01);治疗组的肿瘤体积和瘤重显著减小(P<0.01),体积抑瘤率与重量抑瘤率分别为63.66%和58.98%。组织学示治疗组肿瘤细胞有出血及坏死,TUNEL证实了细胞的凋亡。结论:多聚乙烯基亚胺介导的卵巢特异性启动子调控下的自杀基因对卵巢癌有靶向杀伤作用。 Objective:To study the anti-tumor effects of suicide gene therapy using an ovarian-specific promoter and polyethylenimine(PEI) mediated transfection. Methods:(1)The pOSP1-HSVtk plasmids containing an ovarian-specific promoter were transfected using PEI into the Human ovarian carcinoma cell SKOV3, Human lung carcinoma cell NCI-H460 and Human heptocellular carcinoma cell HepG2. The cytotoxicities resulted from GCV were evaluated using the MTT assay. (2) Ovarian cancer xenograft model was established and the PEI/ pOSP1-HSVtk complex were injected around the xenograft. The expressed TK activities were estimated by monitoring the GCV concentration change using a HPLC assay. The weight of the nude mice, the tumor volumes and tumor weights were all recorded to calculate the tumor inhibition rates by weight and by volume. Histopathological analysis and TUNEL method were also performed. Results:(1) GCV was shown to be toxicity only in SKOV3 cells. (2) Compared with the control group, GCV concentrations in tumor tissues transfected pOSP1-HSVtk were shown to be significantly lower (0.05>P>0.01). The tumor volume and the tumor weight were also significantly decreased in the treated group (P <0.01). The tumor volume inhibition rate and the tumor weight inhibition rate were estimated to be 63. 66% and 58. 98% respectively. Histological examination revealed heavy haemorrhage and necrosis in the tumor tissues, and TUNEL confirmed substantial cell apoptosis in the treated group. Con-elusion:The suicide gene therapy system using an ovarian-specific promoter by polyethylenimine mediated transfection has a targeting killing activity on human ovarian cancer.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2005年第2期111-115,共5页 Chinese Journal of Cancer Biotherapy
  • 相关文献

参考文献9

  • 1Casado E, Nettelbeck DM, Gomez-Navarro J, et al. Transcriptional targeting for ovarian cancer gene therapy[J]. Gynecol Oncol, 2001, 82(2): 229-237.
  • 2贾雪梅,王淑玉.卵巢癌的自杀基因治疗[J].中国肿瘤生物治疗杂志,2003,10(3):216-218. 被引量:1
  • 3Boussif O, Lezoualc′h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine[J]. Proc Natl Acad Sci U S A, 1995, 92(16): 7297-7301.
  • 4Choosakoonkriang S, Lobo BA, Koe GS, et al. Biophysical characterization of PEI/DNA complexes[J]. J Pharm Sci, 2003, 92(8): 1710-1722.
  • 5Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery[J].Bioconjug Chem, 2003,14(5): 934-940.
  • 6Alvarez RD,Gomez-Navarro J,Wang M, et al. Adenoviral-mediated suicide gene therapy for ovarian cancer[J]. Mol Ther, 2000,2(5): 524-530.
  • 7Kircheis R,Wightman L,Wagner E. Design and gene delivery activity of modified polyethylenimines[J]. Adv Drug Deliv Rev, 2001, 53(3): 341-358.
  • 8Lee SJ, Kim HS, Yu R, et al. Novel prostate-specific promoter derived from PSA and PSMA enhancers[J]. Mol Ther, 2002, 6(3): 415-421.
  • 9Selvakumaran M, Bao R, Crijns AP, et al. Ovarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element[J]. Cancer Res, 2001, 61(4): 1291-1295.

二级参考文献20

  • 1徐丛剑,许秀兰,张惜阴,郭忠,丰有吉,金志军,曹斌融,顾健人.逆转录病毒介导Ⅰ型单纯疱疹病毒胸腺嘧啶核苷激酶基因转导卵巢癌细胞的研究[J].中华妇产科杂志,1996,31(11):664-666. 被引量:9
  • 2Kanai F, Kawakani T, Hamade, et al. Adenoviras-mediated transduction of E. coil uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil [ J ]. CancerRes, 1998, 58(9) : 1946-1951.
  • 3Uckert W, Kammertons T, Haack K, et al. Double suicide gene(cytosine deaminase and herpes simplex virus thymidine kinase )but not single gene transfer allows reliable elimination of tumor cells in vivo [J]. Hum Gene Ther, 1998, 9(6) : 855-865.
  • 4Furman PA, Mcguirt PV, Keller PM, et al. Inhibition of ACV of cell growth and DNA synthesis of cells biochcmically transformed with herpes virus genetic information[J]. Virol, 1980, 102: 420-430.
  • 5Freeman SM, Abbound CN, Whartenby KA, et al. The "bystander effectn : Tumor regression when a fraction of the tumor mass is genetically modified[J]. Cancer Res, 1993, 53 : 5274-5283.
  • 6Moolten FL. Tumor Chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy[J]. Cancer Res, 1986, 46: 5276-5281.
  • 7Moolten FL, Wells J-M, Heyman RA, et al. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene[J]. Hum C, ene Ther, 1990, 1 : 125-134.
  • 8Moolten FL, Wells JIM. Curability of tumors bearing herpes thymidine kitmse genes transferred by retroviml vectors[J]. J Nail Cancer Inst, 1990, 82(4) : 297-300.
  • 9Behbakht K, Benjamin I, et al. Adenovirus-mediated gene therapy of ovarian cancer in a mouse model [ J ]. Am J Obstet Gynecol,1996, 175(5): 1260-1265.
  • 10Tong XW, Block A, Chen SH, et al. in vivo gene therapy of ovarian cancer by adenoviras-mediated thymidine kinase transduction and gancidovir administration [ J ]. Gynecol Oncol, 1996, 61 :175-179.

同被引文献14

  • 1尹冰楠,李冬田,李秋香,佟惠春,李光明.高效化学转化菌内同源重组法构建重组腺病毒[J].天津医药,2005,33(7):437-440. 被引量:3
  • 2曹阳,李冬田,尹冰楠,佟惠春.重叠延伸PCR方法的建立与应用[J].河北医药,2005,27(11):803-804. 被引量:6
  • 3Kaplan JM. Adenovirus-based cancer gene therapy[ J]. Curr Gene Ther, 2005, 5(6) : 595-605.
  • 4Ueno NT, Bartholomeusz C, Herrmann JL, et al. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3. ip1 through apoptosis involving the caspase-3 Pathway [J]. Clin Cancer Res, 2000, 6(1) : 250-259.
  • 5Al-Hendy A, Magliocco AM, AI-Tweigeri T, et al. Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovlr improves survival in a novel immunocompetent murine model [ J ]. Am J Obstet Gynecol, 2000, 182(3) : 553-559.
  • 6Bischoff JR, Kirn DH, Williams A, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells [ J ]. Science, 1996, 274(5286) : 373-376.
  • 7Yoon TK, Shichinohe T, Laquerre S, et al. Selectively replicating adenoviruses for oncolytic therapy[ J ]. Curr Cancer Drug Targets, 2001, 1(2) : 85-107.
  • 8McCormick F. ONYX-015 selectivity and the p14ARF pathway[J]. Oncogene, 2000, 19(56): 6670-6672.
  • 9Ffisch SM. E1A as a tumor suppressor[J]. Clin Cancer Res, 2004, 10 (9) : 2905-2907.
  • 10Portsmouth D, Hlavaty J, Renner M. Suicide genes for cancer therapy[J]. Mol Aspects Med, 2007, 28(1) : 4-41.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部